Command Palette
Search for a command to run...
Yatharth Hospital
NSE: YATHARTHBSE: 543950HEALTHCAREHEALTHCARE FACILITIES
Market Cap
--
P/E Ratio
0.00
P/B Ratio
0.00
ROE
0.00%
ROA
0.00%
Debt/Equity
0.00
Book Value
₹0.0
EPS
₹0.0
About Yatharth Hospital
Yatharth Hospital & Trauma Care engaged in the business of providing healthcare services, operating hospitals and other allied services, as may be required for the provision of healthcare services.
Yatharth Hospital & Trauma Care Services Limited was formerly incorporated as a Private Limited Company in Delhi dated February 28, 2008. On November 3, 2021, the status converted into a Public Company and name of the Company was changed to `Yatharth Hospital & Trauma Care Services Limited' on November 18, 2021 issued by the RoC. Yatharth Hospitals and Trauma Care Services Limited is a network of super speciality hospitals across Delhi National Capital Region (NCR) and Madhya Pradesh, capitalising on the robust healthcare infrastructure in these regions to serve a wide patient base in need of tertiary care. The Company operate three super specialty hospitals in Delhi NCR, i.e., at Greater Noida, Uttar Pradesh. The super speciality tertiary care hospital currently operates with 400 beds, including 112 critical care beds and 9 modular operation theatres, among other surgical facilities. I. At present, the Company is engaged in provision of healthcare services. The Company started operations in 2008 with a clinic in Noida, Uttar Pradesh and thereafter, established its first hospital in Greater Noida, Uttar Pradesh in November 2010. The second hospital in Noida, Uttar Pradesh commenced operations in 2013 as a 250-bedded super-specialty tertiary care hospital. The third hospital located in Noida Extension, Uttar Pradesh is a 450-bedded tertiary care hospital with a mix of 11 modular and other operation theatres. It also has 125 critical care beds, and had commenced operations in May 2019. In February 2022, the Company acquired a 305-bedded Ramraja Multi-Speciality Hospital in Orchha, Madhya Pradesh near Jhansi, Uttar Pradesh, which commenced commercial operations effective from April 10, 2022. The Company made an Initial Public Offer by raising funds from public aggregating to Rs 686.56 Crore by issuing upto 22,885,023 Equity Shares, comprising a Fresh Issue of 16,333,333 Equity Shares aggregating to Rs 490 Crore and an Offer for Sale of 6,551,690 Equity Shares aggregating to Rs 196.56 Crore in July, 2023. In 2024, Yatharth Hospitals, marked the launching of Radiation Oncology and Nuclear Medicine Center at the NOIDA Extension Facility. It acquired the fifth hospital, in Faridabad, Haryana, adding 200 beds in February, 2024 and made it operational in May 2024. Further, Company acquired two hospitals, first in Model Town, Delhi and second in Sector 20, Faridabad, Haryana in FY2025.
Price Action • YATHARTH
Financial Statements
Consolidated & Standalone Reports
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|---|---|
Total Revenue | 510.5 | 465.93 | 433.34 | 373.11 | 299.86 | 165.24 | 132.85 |
Operating Expenses | 364.26 | 327.22 | 302.48 | 266.21 | 214.42 | 123.02 | 101.81 |
Operating Profit | 125.58 | 127.02 | 117.31 | 105.31 | 84.18 | 41.71 | 30.9 |
Operating Margin (%) | - | 27.26 | 27.07 | 28.22 | 28.07 | 25.24 | 23.26 |
Total Expenses | - | 346.5 | 320.23 | 287.59 | 239.54 | 147.21 | 129.96 |
EBITDA | - | 138.71 | 130.86 | 106.9 | 85.45 | 42.22 | 31.04 |
EBITDA Margin (%) | - | 29.77 | 30.2 | 28.65 | 28.5 | 25.55 | 23.36 |
Interest Expenses | 0.64 | 0.62 | 4.3 | 8.74 | 11.96 | 11.67 | 13.32 |
Depreciation | 20.9 | 18.66 | 13.44 | 12.64 | 13.16 | 12.52 | 14.83 |
Profit Before Tax (PBT) | 124.7 | 119.43 | 113.12 | 85.52 | 60.32 | 18.03 | 2.88 |
Tax Expenses | 32.79 | 31.74 | 29.12 | 21.35 | 18.23 | 2.52 | 2.09 |
PAT Before Extraordinary Items | - | 87.69 | 83.99 | 64.17 | 42.09 | 15.5 | 0.8 |
Net Profit | 91.91 | 87.69 | 83.99 | 64.17 | 42.09 | 15.5 | 0.8 |
Net Profit Margin (%) | - | 19.3 | 20 | 17.27 | 14.09 | 9.41 | 0.59 |
EPS (Adjusted) | - | 9.1 | 8.72 | 6.66 | 4.37 | 1.61 | 0.08 |
Valuation & Key Ratios
Performance Metrics
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|---|---|
Book Value Per Share | - | 158.28 | 97.49 | 26.88 | 17.05 | 43.89 | 34.42 |
Return on Assets (ROA) % | - | 5.56 | 9.56 | 19.67 | 14.72 | 7.46 | 0.39 |
Return on Equity (ROE) % | - | 5.74 | 10.03 | 36.43 | 37.67 | 21.56 | 1.41 |
Return on Capital Employed (ROCE) % | - | 7.81 | 13.89 | 35.63 | 36.72 | 17.77 | 9.12 |
Profitability Ratios | - | - | - | - | - | - | - |
Liquidity Ratios | - | - | - | - | - | - | - |
Valuation Ratios | - | - | - | - | - | - | - |
Debt to Equity Ratio | - | 0 | 0 | 0.65 | 0.98 | 1.25 | 2.07 |
Featured Insight
No recent news available
Key People
M
Mr. Amit Kumar Singh
Chief Executive Officer
M
Mr. Nitin Gupta
President(Finance),Group Chief Operating Officer
M
Mr. Pankaj Prabhakar
Chief Financial Officer
M
Mr. Sonu Goyal
Chief Financial Controller
R
Ritesh Mishra
Company Secretary,Compliance Officer